| | 357336-20-0 Basic information More.. |
| Product Name: | Brivaracetam | | Synonyms: | UCB-34714;2(S)-[2-Oxo-4(R)-propylpyrrolidin-1-yl]butyramide;API-Anti Epilepsy;brivaracetam;BrivaracetamL;1-Pyrrolidineacetamide,a-ethyl-2-oxo-4-propyl-, (aS,4R)-;brivaracetam USP/EP/BP;Brivaracetam Impurity 43 | | CAS: | 357336-20-0 | | MF: | C11H20N2O2 | | MW: | 212.29 | | EINECS: | 801-184-2 | | Mol File: | 357336-20-0.mol |  |
Use
Brivaracetam, a chemical analog of Levetiracetam, is a racetam derivative with anticonvulsant effect. It is used for the treatment of partial-onset seizures with or without secondary generalisation, in combination with other antiepileptic drugs. The exact mechanism of brivaracetam's anti-epileptogenic activity is unknown. What is known is thatbrivaracetam binds SV2A with high affinity. SV2A is known to play a role in epileptogenesis through modulation of synaptic GABA release. It is thought that brivaracetam exerts its anti-epileptogenic effects through its binding to SV2A. Brivaracetam can also inhibit Na+ channels which may also contribute to its anti-epileptogenic action.
- brivaracetam
-
- US $1.00 / g
- 2024-04-24
- CAS:357336-20-0
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 100kg
- Brivaracetam
-
- US $0.00 / Kg/Bag
- 2024-04-22
- CAS:357336-20-0
- Min. Order: 2Kg/Bag
- Purity: 99% up, High Density
- Supply Ability: 20 tons
|
|
357336-20-0
Recommend Suppliers |
|